Vimarsana
Biggest News Aggregation in the World

Vericel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vericel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vericel Today - Breaking & Trending Today

Analyzing Genocea Biosciences (NASDAQ:GNCAQ) and Vericel (NASDAQ:VCEL) - Vimarsana News

Analyzing Genocea Biosciences (NASDAQ:GNCAQ) and Vericel (NASDAQ:VCEL)

Vericel (NASDAQ:VCEL – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Analyst Recommendations This is a breakdown of recent ratings […]

Louisiana State Employees Retirement System Invests $851,000 in Vericel Co. (NASDAQ:VCEL) - Vimarsana News

Louisiana State Employees Retirement System Invests $851,000 in Vericel Co. (NASDAQ:VCEL)

Louisiana State Employees Retirement System bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 23,900 shares of the biotechnology company’s stock, valued at approximately $851,000. Louisiana State Employees Retirement System owned 0.05% of Vericel […]

Here's Why Shareholders May Want To Be Cautious With Increasing Vericel Corporation's (NASDAQ:VCEL) CEO Pay Packet - Vimarsana News

Here's Why Shareholders May Want To Be Cautious With Increasing Vericel Corporation's (NASDAQ:VCEL) CEO Pay Packet

Key Insights Vericel's Annual General Meeting to take place on 1st of May Salary of US$790.0k is part of CEO Nick...

Source: yahoo.com
Truist Financial Reaffirms "Buy" Rating for Vericel (NASDAQ:VCEL) - Vimarsana News

Truist Financial Reaffirms "Buy" Rating for Vericel (NASDAQ:VCEL)

Truist Financial reissued their buy rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $54.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued research reports about the company. HC Wainwright upped their price objective on Vericel […]

Vericel (NASDAQ:VCEL) Trading Down 7.4% - Vimarsana News

Vericel (NASDAQ:VCEL) Trading Down 7.4%

Vericel Co. (NASDAQ:VCEL – Get Free Report) shares fell 7.4% during mid-day trading on Thursday . The stock traded as low as $43.87 and last traded at $44.27. 384,117 shares traded hands during trading, a decline of 40% from the average session volume of 635,116 shares. The stock had previously closed at $47.80. Wall Street […]